GNW
Genworth Financial, Inc. [GNW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GNW Stock Summary
Top GNW Correlated Resources
GNW
Top 10 Correlated ETFs
GNW
Top 10 Correlated Stocks
GNW
In the News
GNW Financial details
Company Rating
Neutral
Market Cap
2.62B
Income
48M
Revenue
5.44B
Book val./share
16.64
Cash/share
7.98
Dividend
-
Dividend %
-
Employees
2.7K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
59.45
Forward P/E
-
PEG
-6.33
P/S
0.52
P/B
0.38
P/C
0.75
P/FCF
3.81
Quick Ratio
-1.23
Current Ratio
-0.23
Debt / Equity
0.21
LT Debt / Equity
0.19
-
-
EPS (TTM)
0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-86.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-31.09%
Revenue last 5Y
-3.11%
Revenue Q/Q
-19.12%
EPS Q/Q
-846.03%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
197.05%
Inst Trans
2.71%
ROA
-
ROE
1%
ROC
-
Gross Margin
100%
Oper. Margin
7%
Profit Margin
1%
Payout
8%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.51-6.93
52W High
-0.83%
52W Low
+48.75%
RSI
38
Rel Volume
0.45
Avg Volume
2.8M
Volume
1.27M
Perf Week
0%
Perf Month
-4.19%
Perf Quarter
2.41%
Perf Half Y
-2.94%
-
-
-
-
Beta
1.074
-
-
Volatility
0.05%, 0.21%
Prev Close
1.19%
Price
5.95
Change
2.06%
GNW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 16.1 | 17.14 | 15.45 | 14.88 | 14.75 | |
| Net income per share | 1.03 | 1.51 | 1.68 | 1.21 | 0.16 | |
| Operating cash flow per share | 4.13 | 3.88 | 0.86 | 2.08 | 1.27 | |
| Free cash flow per share | 4.13 | 4.41 | 0.86 | 2.08 | 2.09 | |
| Cash per share | 127.1 | 290.64 | 266.67 | 214.06 | 7.65 | |
| Book value per share | 28.21 | 30.32 | 30.6 | 19.79 | 15.96 | |
| Tangible book value per share | 194 | 201.94 | 191.65 | 20.81 | 17.36 | |
| Share holders equity per share | 28.21 | 30.32 | 30.6 | 19.79 | 15.96 | |
| Interest debt per share | 8.4 | 9.4 | 4.06 | 3.42 | 3.65 | |
| Market cap | 2.21B | 1.91B | 2.05B | 2.67B | 3.13B | |
| Enterprise value | 2.46B | -75.11B | -70.54B | -57.11B | 2.55B | |
| P/E ratio | 4.26 | 2.51 | 2.42 | 4.38 | 41.21 | |
| Price to sales ratio | 0.27 | 0.22 | 0.26 | 0.36 | 0.45 | |
| POCF ratio | 1.06 | 0.97 | 4.7 | 2.54 | 5.25 | |
| PFCF ratio | 1.06 | 0.86 | 4.7 | 2.54 | 3.19 | |
| P/B Ratio | 0.16 | 0.12 | 0.13 | 0.27 | 0.42 | |
| PTB ratio | 0.16 | 0.12 | 0.13 | 0.27 | 0.42 | |
| EV to sales | 0.3 | -8.68 | -9.01 | -7.61 | 0.37 | |
| Enterprise value over EBITDA | 4.57 | -167.65 | -60.45 | -59.86 | 12.81 | |
| EV to operating cash flow | 1.18 | -38.32 | -161.43 | -54.44 | 4.27 | |
| EV to free cash flow | 1.18 | -33.73 | -161.43 | -54.44 | 2.6 | |
| Earnings yield | 0.23 | 0.4 | 0.41 | 0.23 | 0.02 | |
| Free cash flow yield | 0.94 | 1.17 | 0.21 | 0.39 | 0.31 | |
| Debt to equity | 0.28 | 0.3 | 0.12 | 0.16 | 0.21 | |
| Debt to assets | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | |
| Net debt to EBITDA | 0.46 | -171.92 | -62.21 | -62.66 | -2.93 | |
| Current ratio | -14.1 | -22.47 | -18.36 | -0.43 | -0.23 | |
| Interest coverage | 2.25 | 2.22 | 7.29 | 6.97 | 1.69 | |
| Income quality | 4.01 | 2.58 | 0.48 | 1.42 | 7.86 | |
| Dividend Yield | 0.04 | 0 | 0.02 | 0.02 | 0.01 | |
| Payout ratio | 0.17 | 0 | 0.04 | 0.08 | 0.51 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0.14 | 0 | 0 | 0.64 | |
| Capex to revenue | 0 | 0.03 | 0 | 0 | 0.06 | |
| Capex to depreciation | 0 | -0.47 | 0 | 0 | 9.6 | |
| Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0.01 | |
| Graham number | 25.59 | 32.06 | 33.98 | 23.19 | 7.63 | |
| ROIC | 0.02 | 0.02 | 0.05 | 0.05 | 0.01 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham Net | 140.1 | 305.45 | 284.17 | 9.41 | -170.17 | |
| Working capital | 86.77B | 101.72B | 96.28B | 5.99B | 22.6B | |
| Tangible asset value | 97.57B | 102.02B | 97.15B | 10.5B | 8.14B | |
| Net current asset value | 77.45B | 93.86B | 89.43B | -73.9B | -59.39B | |
| Invested capital | 0.28 | 0.3 | 0.12 | 0.16 | 0.21 | |
| Average receivables | 17.19B | 16.96B | 16.82B | 16.62B | 17.73B | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | -2.71B | -4.32B | -3.47B | -41.71B | -73.86B | |
| Days sales outstanding | 771.07 | 709.05 | 783.55 | 799.09 | 1K | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 43.18K | |
| Receivables turnover | 0.47 | 0.51 | 0.47 | 0.46 | 0.36 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0.01 | |
| ROE | 0.04 | 0.05 | 0.05 | 0.06 | 0.01 | |
| Capex per share | 0 | 0.53 | 0 | 0 | 0.82 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.82 | 3.77 | 0.59 | 3.98 | 3.3 | |
| Net income per share | 0.35 | 0.19 | 0.29 | 0.06 | -0.47 | |
| Operating cash flow per share | 0.81 | 0.03 | 0.55 | 0.38 | 0.33 | |
| Free cash flow per share | 0.81 | 0.03 | 0.55 | 0.57 | 0.45 | |
| Cash per share | 217.38 | 99.8 | 11.87 | 99.81 | 7.98 | |
| Book value per share | 20.1 | 15.1 | 9.25 | 17.49 | 16.64 | |
| Tangible book value per share | 21.14 | 184.82 | 187.87 | 181.68 | 18.11 | |
| Share holders equity per share | 20.1 | 15.1 | 9.25 | 17.49 | 16.64 | |
| Interest debt per share | 3.31 | 3.31 | 1.6 | 3.54 | 3.61 | |
| Market cap | 2.63B | 2.47B | 2.37B | 2.7B | 3B | |
| Enterprise value | -57.15B | 2.32B | 2.42B | 2.31B | 2.42B | |
| P/E ratio | 3.75 | 6.57 | 4.32 | 23.26 | -3.54 | |
| Price to sales ratio | 1.39 | 1.33 | 8.53 | 1.47 | 2.03 | |
| POCF ratio | 6.5 | 145.37 | 9.17 | 15.42 | 20.42 | |
| PFCF ratio | 6.5 | 145.37 | 9.17 | 10.34 | 14.94 | |
| P/B Ratio | 0.26 | 0.33 | 0.54 | 0.33 | 0.4 | |
| PTB ratio | 0.26 | 0.33 | 0.54 | 0.33 | 0.4 | |
| EV to sales | -30.16 | 1.25 | 8.72 | 1.26 | 1.63 | |
| Enterprise value over EBITDA | -220.66 | 24.67 | 11.35 | 38.46 | -78.03 | |
| EV to operating cash flow | -141.46 | 136.43 | 9.37 | 13.19 | 16.46 | |
| EV to free cash flow | -141.46 | 136.43 | 9.37 | 8.84 | 12.03 | |
| Earnings yield | 0.07 | 0.04 | 0.06 | 0.01 | -0.07 | |
| Free cash flow yield | 0.15 | 0.01 | 0.11 | 0.1 | 0.07 | |
| Debt to equity | 0.16 | 0.22 | 0.17 | 0.2 | 0.21 | |
| Debt to assets | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Net debt to EBITDA | -230.81 | -1.62 | 0.25 | -6.52 | 18.81 | |
| Current ratio | -0.43 | -3.64 | -0.31 | -2.71 | -0.23 | |
| Interest coverage | 6.25 | 4.48 | 16.5 | 2 | -1.03 | |
| Income quality | 1.98 | 0.18 | 1.14 | 2.92 | -0.7 | |
| Dividend Yield | 0.02 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.24 | 0.04 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0.49 | 0.37 | |
| Capex to revenue | 0 | 0 | 0 | 0.05 | 0.04 | |
| Capex to depreciation | 0 | 0 | 0 | -1.13 | 0.72 | |
| Stock based compensation to revenue | 0 | 0.01 | 0.04 | 0.01 | 0.01 | |
| Graham number | 12.62 | 8.05 | 7.76 | 4.98 | 13.29 | |
| ROIC | 0.01 | 0.01 | 0.03 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 9.55 | 125.76 | 6.03 | 101.49 | -177.51 | |
| Working capital | 5.99B | 87.55B | 24.08B | 62.93B | 22.6B | |
| Tangible asset value | 10.5B | 90.99B | 88.9B | 83.67B | 8.14B | |
| Net current asset value | -73.9B | 68.69B | 4.92B | 44.36B | -59.39B | |
| Invested capital | 0.16 | 0.22 | 0.17 | 0.2 | 0.21 | |
| Average receivables | 16.5B | 17.99B | 9.79B | 8.82B | 18.31B | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | -80.12B | -41.74B | -3.94B | -12.87B | -44.83B | |
| Days sales outstanding | 780.55 | 948.64 | 14.12 | 864.86 | 1.16K | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0.12 | 0.09 | 6.38 | 0.1 | 0.08 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.02 | 0.01 | 0.03 | 0 | -0.03 | |
| Capex per share | 0 | 0 | 0 | 0.19 | 0.12 |
GNW Frequently Asked Questions
What is Genworth Financial, Inc. stock symbol ?
Genworth Financial, Inc. is a US stock , located in Richmond of Va and trading under the symbol GNW
What is Genworth Financial, Inc. stock quote today ?
Genworth Financial, Inc. stock price is $5.95 today.
Is Genworth Financial, Inc. stock public?
Yes, Genworth Financial, Inc. is a publicly traded company.
Company Profile
- Volume Average 2.8M
- Market Capitalization 2.62B
- Employee 2.7K
- CEO Mr. Thomas Joseph McInerney
- Headquarters Richmond,VA,US
- IPO Date 2004-05-25
-
Website
https://www.genworth.com 
Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.
